Compound ID | 1322
| Spectrum of activity: | Gram-positive |
| Institute where first reported: | Department of Pharmaceutical Science and Research, School of Pharmacy, and Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3117 and https://pubchem.ncbi.nlm.nih.gov/compound/5455 |
| DrugBank link: | https://www.drugbank.ca/drugs/DB00822 |
| Citations: |
|